Phase 1 Myocardial Infarction Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

A Phase 1, randomized, double-blind, placebo-controlled study to investigate the safety, tolerability and pharmacokinetics of intravenously infused IB409 in healthy adult participants

Myocardial Infarction

Infensa Bioscience Pyt Ltd48 enrolled1 locationACTRN12625001006437

Completed

Phase 1

A Phase I Randomised, Double-Blind, Placebo-Controlled Dose Escalating Study of the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Oral NP202 in Adult Healthy Volunteers

Cardiac remodelling post acute myocardial infarction

NeuProtect Pty Ltd64 enrolled1 locationACTRN12614000479606

Recruiting

Phase 1

ERYTHROPOIETIN STUDY

Acute Myocardial Infarction (AMI)

Eastern Heart Clinic20 enrolled1 locationACTRN12606000238572